COVID-19 vaccine safety and efficacy in patients with immune-mediated inflammatory disease: review of available evidence
S Wack, T Patton, LK Ferris - Journal of the American Academy of …, 2021 - Elsevier
Dermatologists diagnose and treat many immune-mediated inflammatory diseases (IMID).
Understanding the inherent immune dysregulation of these diseases as well as the …
Understanding the inherent immune dysregulation of these diseases as well as the …
ANCA-associated vasculitis following ChAdOx1 nCoV19 vaccination: case-based review
A Prabhahar, G Naidu, P Chauhan, A Sekar… - Rheumatology …, 2022 - Springer
For the foreseeable future, vaccines are the cornerstone in the global campaign against the
Coronavirus Disease-19 (COVID-19) pandemic. As the number and fatalities due to COVID …
Coronavirus Disease-19 (COVID-19) pandemic. As the number and fatalities due to COVID …
COVID‐19 vaccination in autoimmune diseases (COVAD) study: vaccine safety in idiopathic inflammatory myopathies
A Gil‐Vila, N Ravichandran… - Muscle & …, 2022 - Wiley Online Library
Abstract Introduction/Aims In this study we investigated COVID‐19 vaccination–related
adverse events (ADEs) 7 days postvaccination in patients with idiopathic inflammatory …
adverse events (ADEs) 7 days postvaccination in patients with idiopathic inflammatory …
Side effects and flares risk after SARS-CoV-2 vaccination in patients with systemic lupus erythematosus
E Zavala-Flores, J Salcedo-Matienzo… - Clinical …, 2022 - Springer
The objective of this study is to identify post SARS-CoV-2 vaccine BNT162b2 (BioNTech &
Pfizer) side effects in patients with systemic lupus erythematosus (SLE) at the Cayetano …
Pfizer) side effects in patients with systemic lupus erythematosus (SLE) at the Cayetano …
COVID-19 vaccine safety and nocebo-prone associated hesitancy in patients with systemic rheumatic diseases: a cross-sectional study
GE Fragoulis, VK Bournia, E Mavrea… - Rheumatology …, 2022 - Springer
Objective To describe the rate and type of adverse effects (AEs) and the frequency of
disease flares after COVID-19 vaccination and to assess the reasons for vaccination …
disease flares after COVID-19 vaccination and to assess the reasons for vaccination …
SARS-CoV-2 vaccination in patients with multiple sclerosis in Germany and the United Kingdom: Gender-specific results from a longitudinal observational study
N Frahm, F Fneish, D Ellenberger, J Haas… - The Lancet Regional …, 2022 - thelancet.com
Background Vaccines offer people with multiple sclerosis (PwMS) an effective protection
against severe COVID-19 disease courses. However, representative real-world data on the …
against severe COVID-19 disease courses. However, representative real-world data on the …
Safety of SARS-CoV-2 vaccination in patients with Behcet's syndrome and familial Mediterranean fever: a cross-sectional comparative study on the effects of M-RNA …
A Ozdede, S Guner, G Ozcifci, B Yurttas… - Rheumatology …, 2022 - Springer
Most of the published data relate to classical forms of rheumatic diseases (RD) and
information on rare inflammatory disorders such as Behçet's syndrome (BS) and familial …
information on rare inflammatory disorders such as Behçet's syndrome (BS) and familial …